138 related articles for article (PubMed ID: 19779716)
1. CD4(+)CD45RA(+)CXCR4 (+) lymphocytes are inversely associated with progression in stages I-III melanoma patients.
Napolitano M; Ottaiano A; Mauro F; Ieranò C; Satriano R; Pacelli R; Franco R; De Angelis V; Castello G; Scala S
Cancer Immunol Immunother; 2010 Apr; 59(4):511-7. PubMed ID: 19779716
[TBL] [Abstract][Full Text] [Related]
2. CCR5 and CXCR4 expression on memory and naive T cells in HIV-1 infection and response to highly active antiretroviral therapy.
Nicholson JK; Browning SW; Hengel RL; Lew E; Gallagher LE; Rimland D; McDougal JS
J Acquir Immune Defic Syndr; 2001 Jun; 27(2):105-15. PubMed ID: 11404531
[TBL] [Abstract][Full Text] [Related]
3. Flow cytometric characterisation of the "false naive" (CD45RA+, CD45RO-, CD29 bright+) peripheral blood T-lymphocytes in health and in rheumatoid arthritis.
Neidhart M; Pataki F; Schönbächler J; Brühlmann P
Rheumatol Int; 1996; 16(2):77-87. PubMed ID: 8853229
[TBL] [Abstract][Full Text] [Related]
4. The levels of memory (CD45RA-, RO+) CD4+ and CD8+ peripheral blood T-lymphocytes correlate with IgM rheumatoid factors in rheumatoid arthritis.
Neidhart M; Fehr K; Pataki F; Michel BA
Rheumatol Int; 1996; 15(5):201-9. PubMed ID: 8717104
[TBL] [Abstract][Full Text] [Related]
5. Changes on distribution of CD4+/CD45RA- and CD8+/CD11- cells in tumor-infiltrating lymphocytes of renal cell carcinoma associated with tumor progression.
Igarashi T; Murakami S; Takahashi H; Matsuzaki O; Shimazaki J
Eur Urol; 1992; 22(4):323-8. PubMed ID: 1362703
[TBL] [Abstract][Full Text] [Related]
6. Soluble interleukin-2 receptor in stage I-III melanoma.
Ottaiano A; Leonardi E; Simeone E; Ascierto PA; Scala S; Calemma R; Bryce J; Caracò C; Satriano RA; Gianfranco N; Franco R; Botti G; Castello G
Cytokine; 2006 Feb; 33(3):150-5. PubMed ID: 16517174
[TBL] [Abstract][Full Text] [Related]
7. The prognostic role of CD4+ and CD8+ lymphocytes during chemoimmunotherapy in metastatic melanoma.
Hernberg MM; Hahka-Kemppinen MH; Pyrhönen SO
Melanoma Res; 2004 Dec; 14(6):493-500. PubMed ID: 15577320
[TBL] [Abstract][Full Text] [Related]
8. Effects of human immunodeficiency virus type 1 infection on CCR5 and CXCR4 coreceptor expression on CD4 T lymphocyte subsets in infants and adolescents.
Tuttle DL; Coberley CR; Xie X; Kou ZC; Sleasman JW; Goodenow MM
AIDS Res Hum Retroviruses; 2004 Mar; 20(3):305-13. PubMed ID: 15117454
[TBL] [Abstract][Full Text] [Related]
9. The clinical implication of CD45RA
Hang J; Huang J; Zhou S; Wu L; Zhu Y; Zhu L; Zhou H; Xu K; Jiang H; Yang X
Cancer Med; 2019 Mar; 8(3):1326-1335. PubMed ID: 30767430
[TBL] [Abstract][Full Text] [Related]
10. The predictive value of CD8, CD4, CD68, and human leukocyte antigen-D-related cells in the prognosis of cutaneous malignant melanoma with vertical growth phase.
Piras F; Colombari R; Minerba L; Murtas D; Floris C; Maxia C; Corbu A; Perra MT; Sirigu P
Cancer; 2005 Sep; 104(6):1246-54. PubMed ID: 16078259
[TBL] [Abstract][Full Text] [Related]
11. The number of CCR5 expressing CD4+ T lymphocytes is lower in HIV-infected long-term non-progressors with viral control compared to normal progressors: a cross-sectional study.
Meijerink H; Indrati AR; van Crevel R; Joosten I; Koenen H; van der Ven AJ
BMC Infect Dis; 2014 Dec; 14():683. PubMed ID: 25495598
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of CXCR4 in primary tumor of patients with HER-2 negative breast cancer was predictive of a poor disease-free survival: a validation study.
Mizell J; Smith M; Li BD; Ampil F; Chu QD
Ann Surg Oncol; 2009 Oct; 16(10):2711-6. PubMed ID: 19593633
[TBL] [Abstract][Full Text] [Related]
13. Accelerated in vivo proliferation of memory phenotype CD4+ T-cells in human HIV-1 infection irrespective of viral chemokine co-receptor tropism.
Zhang Y; de Lara C; Worth A; Hegedus A; Laamanen K; Beverley P; Macallan D
PLoS Pathog; 2013; 9(4):e1003310. PubMed ID: 23637601
[TBL] [Abstract][Full Text] [Related]
14. CXC chemokine receptor 4 is expressed in uveal malignant melanoma and correlates with the epithelioid-mixed cell type.
Scala S; Ieranò C; Ottaiano A; Franco R; La Mura A; Liguori G; Mascolo M; Staibano S; Ascierto PA; Botti G; De Rosa G; Castello G
Cancer Immunol Immunother; 2007 Oct; 56(10):1589-95. PubMed ID: 17410362
[TBL] [Abstract][Full Text] [Related]
15. Increased frequencies of the CD29 and CD57 markers and decreased frequency of CD45RA within CD4+ and CD8+ subsets after allogeneic bone marrow transplantation in man.
Møller J; Dickmeiss E; Ryder LP; Jacobsen N; Svejgaard A
Scand J Immunol; 1991 May; 33(5):499-504. PubMed ID: 1709516
[TBL] [Abstract][Full Text] [Related]
16. [Deep lung--cellular reaction to HIV].
Tavares Marques MA; Alves V; Duque V; Botelho MF
Rev Port Pneumol; 2007; 13(2):175-212. PubMed ID: 17492233
[TBL] [Abstract][Full Text] [Related]
17. Serum levels of interleukin-1 beta, luteinizing hormone, and prolactin correlate with the expression of CD45 isoforms on CD4+ peripheral blood T lymphocytes in healthy women.
Neidhart M
Ann Hematol; 1997 Oct; 75(4):155-9. PubMed ID: 9402849
[TBL] [Abstract][Full Text] [Related]
18. Expression of CXCR4 predicts poor prognosis in patients with malignant melanoma.
Scala S; Ottaiano A; Ascierto PA; Cavalli M; Simeone E; Giuliano P; Napolitano M; Franco R; Botti G; Castello G
Clin Cancer Res; 2005 Mar; 11(5):1835-41. PubMed ID: 15756007
[TBL] [Abstract][Full Text] [Related]
19. Chemokine receptor patterns in lymphocytes mirror metastatic spreading in melanoma.
Jacquelot N; Enot DP; Flament C; Vimond N; Blattner C; Pitt JM; Yamazaki T; Roberti MP; Daillère R; Vétizou M; Poirier-Colame V; Semeraro M; Caignard A; Slingluff CL; Sallusto F; Rusakiewicz S; Weide B; Marabelle A; Kohrt H; Dalle S; Cavalcanti A; Kroemer G; Di Giacomo AM; Maio M; Wong P; Yuan J; Wolchok J; Umansky V; Eggermont A; Zitvogel L
J Clin Invest; 2016 Mar; 126(3):921-37. PubMed ID: 26854930
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of the chemokine receptors CXCR4, CCR7, CCR9, and CCR10 in human primary cutaneous melanoma: a potential prognostic value for CCR7 and CCR10?
Kühnelt-Leddihn L; Müller H; Eisendle K; Zelger B; Weinlich G
Arch Dermatol Res; 2012 Apr; 304(3):185-93. PubMed ID: 22350183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
